Propofol versus Propofol combined with Dezocine for flexible bronchoscopy: A Randomized Study

Status

Recruiting

Phases

Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR-IPC-14005348

Enrollment

Unknown

Registered

2014-10-17

Start date

2014-11-01

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Propofol versus Propofol combined with Dezocine for flexible bronchoscopy

Interventions

PD:propofol combined with dezocine

P:propofol

Eligibility

Sex/Gender

All

Age

18 Years to 75 Years

Inclusion criteria

Inclusion criteria: The patients, aged between 18 to 75 years, with American Society of Anesthesiologists (ASA) physical classification system status of I to III.

Exclusion criteria

Exclusion criteria: psychological disorders; hypersensitivity or allergy to the study drugs; uncontrolled hypertension (uncontrolled hypertension with blood pressure higher than 140/90 mmHg); major abnormalities of liver function; ischemic heart disease and severe respiratory disease.

Design outcomes

Primary

Measure	Time frame
Pulse oxygen saturation;Heart rate;Mean arterial pressure;respiratory rates;time to initial sedation;total dosage of propofol;	—

Secondary

Measure	Time frame
cough scores;discomfort scores;	—

Countries

China

Contacts

Public ContactTieli Dong

tlddtl@126.com+86 13783692658

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026